通过使用高压氧气疗法的埃托芬胺注射诱导的尼古拉综合征的有效治疗
Gökçe Işil Kurmuş1, Demet Şensoy Söğüt1, Dilek Menteşoğlu1
1Department of Dermatology & Venereology, Ankara Etlik City Hospital, Ankara, Turkey.
Advances in skin & wound care
|October 29, 2025
概括
尼古拉氏综合征 (NS) 是一种罕见的注射并发症,导致皮肤亡. 高压氧气疗法 (HBOT) 有效地治疗了患有NS的患者,导致完全愈合和痕最小.
科学领域:
- 皮肤病学 皮肤病学
- 伤口愈合 治愈 伤口愈合
- 高压医学的高压医学.
背景情况:
- 尼古拉氏综合征 (NS) 是一种罕见但严重的阳性并发症.
- 在肌内注射后,它呈现为皮肤亡.
- 早期识别和管理至关重要.
研究的目的:
- 报告一个成功用高压氧疗法 (HBOT) 治疗的NS病例.
- 为了评估HBOT在治疗由埃托芬胺诱导的NS中的疗效.
- 突出全面的NS管理的好处.
主要方法:
- 一名51岁的女性患者在注射埃托芬胺后被诊断出NS.
- 治疗包括局部伤口护理和30次HBOT治疗.
- 监测了愈和痕的临床结果.
主要成果:
- 患者实现了性的完全治愈.
- 剩余的低颜色痕是唯一的后果.
- 高血压治疗促进了有效的伤口关闭和组织修复.
结论:
- 高压氧气疗法是一种有效的治疗NS由肌肉内埃托芬胺引起的.
- HBOT促进了的完整愈合,并最大限度地减少了长期的痕.
- 包括HBOT在内的综合管理对于最佳的NS结果至关重要.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
580
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
580
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
433
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
433
Pulmonary Embolism III: Nursing Management
351
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
351
Acute Respiratory Failure-V
448
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
448
Drug Delivery: Enteral Route
1.6K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.6K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
452
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
452


